CASR and B-cell non-Hodgkin lymphoma: The findings that FIH+/Δ1-2 and FIHΔ1-2/Δ1-2 mice developed B cell lymphomas with similar tumor onset and spectrum (Fig. 1 B–D) suggest that FIH may be a haploinsufficient tumor suppressor in aging mice.